APPB
Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2019 Q3 | -0.10 | $169,575 | -$52,144 |
| 2019 Q2 | -0.06 | $244,274 | -$366,528 |
| 2019 Q1 | -0.03 | $211,457 | -$399,043 |
| 2019 Q4 | -0.02 | $234,553 | -$117,743 |
| 2018 Q3 | -0.16 | $413,109 | -$495,353 |
| 2018 Q2 | -0.01 | $48,966 | -$131,474 |
| 2018 Q1 | -0.04 | $10,434 | -$162,036 |
| 2018 Q4 | -0.12 | $18,020 | -$255,897 |